Cargando…
Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study
(1) Background: It is well-established that coronavirus disease-2019 (COVID-19) is highly pro-inflammatory, leading to activation of the coagulation cascade. COVID-19-induced hypercoagulability is associated with adverse outcomes and mortality. Current guidelines recommend that hospitalized COVID-19...
Autores principales: | Akinosoglou, Karolina, Savopoulos, Christos, Pouliakis, Abraham, Triantafyllidis, Charalampos, Markatis, Eleftherios, Golemi, Foteini, Liontos, Angelos, Vadala, Charikleia, Papanikolaou, Ilias C., Dimakopoulou, Vasiliki, Xarras, Panagiotis, Varela, Katerina, Kaiafa, Georgia, Mitsianis, Athanasios, Chatzistamati, Anastasia, Randou, Efthalia, Savvanis, Spyridon, Pavlaki, Maria, Efraimidis, Georgios, Samaras, Vasileios, Papazoglou, Dimitrios, Konstantinidou, Alexandra, Panagopoulos, Periklis, Milionis, Haralampos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027745/ https://www.ncbi.nlm.nih.gov/pubmed/35458497 http://dx.doi.org/10.3390/v14040767 |
Ejemplares similares
-
The Role of Tinzaparin in Oncology
por: Dimakakos, Evangelos P., et al.
Publicado: (2017) -
Midday Dipping and Circadian Blood Pressure Patterns in Acute Ischemic Stroke
por: Kakaletsis, Nikolaos, et al.
Publicado: (2023) -
Tinzaparin vs. Nadroparin Safety and Efficacy in Neurosurgery
por: Wilhelmy, Florian, et al.
Publicado: (2021) -
Remdesivir Use in the Real-World Setting: An Overview of Available Evidence
por: Akinosoglou, Karolina, et al.
Publicado: (2023) -
Tixagevimab/Cilgavimab in SARS-CoV-2 Prophylaxis and Therapy: A Comprehensive Review of Clinical Experience
por: Akinosoglou, Karolina, et al.
Publicado: (2022)